Abstract:BACKGROUNDChronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitic and emphysematous components. In one biophysical model, the concentration of mucin on the airway surfaces is hypothesized to be a key variable that controls mucus transport in healthy persons versus cessation of transport in persons with muco-obstructive lung diseases. Under this model, it is postulated that a high mucin concentration produces the sputum and disease progression that are characteristic of chronic bronchitis.METHODSWe characterized the COPD status of 917 participants from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) using questionnaires administered to participants, chest tomography, spirometry, and examination of induced sputum. Total mucin concentrations in sputum were measured with the use of size-exclusion chromatography and refractometry. In 148 of these participants, the respiratory secreted mucins MUC5AC and MUC5B were quantitated by means of mass spectrometry. Data from chronic-bronchitis questionnaires and data on total mucin concentrations in sputum were also analyzed in an independent 94-participant cohort.RESULTSMean (+/- SE) total mucin concentrations were higher in current or former smokers with severe COPD than in controls who had never smoked (3166 +/- 402 vs. 1515 +/- 152 mu g per milliliter) and were higher in participants with two or more respiratory exacerbations per year than in those with zero exacerbations (4194 +/- 878 vs. 2458 +/- 113 mu g per milliliter). The absolute concentrations of MUC5B and MUC5AC in current or former smokers with severe COPD were approximately 3 times as high and 10 times as high, respectively, as in controls who had never smoked. Receiver-operating-characteristic curve analysis of the association between total mucin concentration and a diagnosis of chronic bronchitis yielded areas under the curve of 0.72 (95% confidence interval [CI], 0.65 to 0.79) for the SPIROMICS cohort and 0.82 (95% CI, 0.73 to 0.92) for the independent cohort.CONCLUSIONSAirway mucin concentrations may quantitate a key component of the chronic bronchitis pathophysiologic cascade that produces sputum and mediates disease severity. Studies designed to explore total mucin concentrations in sputum as a diagnostic biomarker and therapeutic target for chronic bronchitis appear to be warranted. (Funded by the National Heart, Lung, and Blood Institute and others.)

Elevated Serum Levels Of Mucin-Associated Antigen In Patients With Acute Respiratory Distress Syndrome

Mir-584 and Mir-146 Are Candidate Biomarkers for Acute Respiratory Distress Syndrome

The Characteristics and Clinical Significance of Mucin Levels in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Disease.

The Relationship Between Soluble Cd74, Scd14 And Severity And Prognosis In Patients With Acute Respiratory Distress Syndrome

Serum MUC5AC Protein Levels Are Correlated with the Development and Severity of Connective Tissue Disease-Associated Pulmonary Interstitial Lesions

Protective and Predictive Role of Mucin1 in Sepsis-Induced ALI/ARDS

Identification of circulating microvesicle‐encapsulated miR‐223 as a potential novel biomarker for ARDS

Expression and Clinical Significance of Mucoprotein MUC5AC in Patients with Chronic Obstructive Pulmonary Disease

Airway Mucin Concentration As a Marker of Chronic Bronchitis

Altered distribution, activation and increased IL-17 production of mucosal-associated invariant T cells in patients with acute respiratory distress syndrome

Expression and evaluation of goblet cell in airway of acute respiratory distress syndrome mice

Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID‐19 patients

[Changes in interleukin-1beta in serum and bronchoalveolar lavage fluid in the patient with acute respiratory distress syndrome].

Mechanism Of Cxc Chemokine Ligand 5 (Cxcl5)/Cxc Chemokine Receptor 2 (Cxcr2) Bio-Axis In Mice With Acute Respiratory Distress Syndrome

Circulating Pulmonary-Originated Epithelial Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis

Diagnostic and Predictive Significance of Serum MiR-141-3p in Acute Respiratory Distress Syndrome Patients with Pulmonary Fibrosis

Immunohistochemistry of Pulmonary Surfactant-Associated Protein A in Acute Respiratory Distress Syndrome.

MUC5AC concentrations in lung lavage fluids are associated with acute lung injury after cardiac surgery

Expressions and Evaluation of CXCL1 and CXCL2 in Lung Tissue of ARDS Mice

Angiopoietin Like 4 As a Clinical Biomarker for Acute Respiratory Distress Syndrome

Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome